About
D1Med develops organoid and organ-on-a-chip technologies, including customized organoid disease models and biobanks, to support pharmaceutical research and drug screening.
Explore D1Med's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.